GO
Loading...

Johnson & Johnson

More

  • The Latest Picks That Paid – Friday Jan. 18th Friday, 18 Jan 2008 | 7:22 PM ET
    Quicker Ticker

    Our traders are good - but you knew that! Check out their latest picks that paid.

  • Your First Move For Thursday Jan. 17th Wednesday, 16 Jan 2008 | 10:11 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • EU Raids Drug Companies in Broad Inquiry Wednesday, 16 Jan 2008 | 10:20 AM ET

    The European Commission raided some of the world's largest drugmakers on Wednesday, launching a broad investigation into whether they made illegal deals or abused patents to limit competition and harm consumers.

  • The 'Supply Chain': Stocks That Beat the S&P Thursday, 10 Jan 2008 | 4:42 PM ET

    Kevin O'Marah, chief strategist at AMR Research, has developed a unique "supply-chain strategy" -- and uses it to compile a Top 25 stocks list that beat the 2007 market hands-down.

  • Stocks Rebound in Late Bargain-Hunting Wednesday, 9 Jan 2008 | 3:01 PM ET

    Stocks closed sharply higher after a late-session rally as investors piled into sectors seen as resistant to economic contraction, such as health care and staples, amid talk of recession.

  • Fast Message – We Answer Your Questions Tuesday, 8 Jan 2008 | 7:18 PM ET

    Time to sort through the Fast Money inbox and answer more of your questions. Gordon writes, “Is 1390 on the S&P low enough to move the next support level - having passed through the 1400 double bottom?”

  • Your First Move For Tuesday Jan. 8th Monday, 7 Jan 2008 | 7:22 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Your First Move For Monday Jan. 7th Friday, 4 Jan 2008 | 7:25 PM ET

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • Amgen: Anemia Drugs Take Yet Another Hit Thursday, 3 Jan 2008 | 4:18 PM ET

    The Food and Drug Administration late this morning put out a news release with the heading, "FDA Receives New data on Risks of Anemia Drugs." This is more bad news for an additional population of cancer patients and, of course, Amgen and, to a lesser extent, Johnson and Johnson.

  • Sector Rotation for Dummies Monday, 24 Dec 2007 | 2:16 PM ET

    There are two kinds of companies in the market – cyclical and secular. One of the most important moves in the game is to know when to shift money from one to the other.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Did Genentech Back Down or Backpedal? Friday, 21 Dec 2007 | 12:11 PM ET

    So, it didn't take long after my Genentech blog entry got posted yesterday for me to receive an email and a voicemail from a Genentech spokesperson requesting a "clarification" on my take regarding the latest chapter in the Avastin vs. Lucentis brouhaha. I think I'm being spun.

  • Most of my PR and professional contacts send Christmas cards, but for the past two years the boutique Wall Street firm, Rodman & Renshaw, has sent me heavy metal piggy banks. I assume the company sends them to its clients as well.

  • Your First Move For Thursday Dec. 13th Wednesday, 12 Dec 2007 | 7:08 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Pharma's Market with Mike Huckman Wednesday, 12 Dec 2007 | 4:30 PM ET

    Last year one of our producers had the bright idea of assigning each of CNBC's beat reporters a story about seven predictions for their beat for 2007. So, now this year not only do we have to do the 8 for '08 thing for TV, but also for the blog.

  • The 2008 Beijing Olympics present an unparalleled marketing opportunity for global brands looking to expand their presence in the dynamic Chinese market.

  • Johnson & Johnson's $4 Billion "Oops, Never Mind!" Friday, 30 Nov 2007 | 1:58 PM ET

    Late yesterday one of the midnight-oil-burning "Squawk Box" producers runs over to my desk asking, "Hey, is this J and J thing a big deal?" I said, "What J and J thing?" "Check the wires," he said. Here's what I saw...

  • US Panel Backs Abbott's Drug-Coated Heart Stent Thursday, 29 Nov 2007 | 9:18 PM ET

    Abbott Laboratories moved closer to joining the U.S. market for drug-coated heart stents on Thursday as an advisory panel backed the company's experimental device.

  • J&J to Focus Beyond Traditional Lines of Business Thursday, 15 Nov 2007 | 1:16 PM ET
    Johnson & Johnson

    Health care products maker Johnson & Johnson, faced with lagging sales of some top products, said Thursday it would create three new units to boost prospects.

  • Buy Wyeth? Tuesday, 13 Nov 2007 | 10:39 AM ET

    What's the best reason to own a pharma stock right now? Consistency in the face of recession.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Warnings Strengthened for Amgen, J&J Anemia Drugs Thursday, 8 Nov 2007 | 1:50 PM ET

    The warning labels have been strengthened on anemia drugs made by Amgen Inc and Johnson & Johnson to reflect concerns they may increase the risk of heart attacks, stroke and death, the companies and U.S. regulators said on Thursday.